top of page
butterfly image.PNG

Butterfly Medical 

Butterfly is a US and Israel based medical device company developing a nitinol implantable device, delivered through a minimally-invasive technique into the prostatic urethra, to open up the prostatic urethra in patients with benign prostatic hyperplasia (BPH), intended to restore urinary flow and provide symptomatic relief.   

​

Butterfly’s anatomically shaped nitinol implant is positioned in the prostatic urethra to open the space and relieve BPH symptoms. The device comes in multiple sizes and, unlike more invasive approaches, does not require resection or burning of prostatic tissue. 

​

In a clinical trial, the device demonstrated benefits in patients suffering from BPH symptoms, with improvement in IPSS (International Prostate Symptoms Score - symptoms severity questionnaire) observed as early as two weeks after the procedure. 

​​​

"The Butterfly team has created an innovative, anatomically-shaped device designed to treat urinary obstruction from BPH, without the significant side-effects seen in drugs or surgical treatments. I chose Butterfly because I saw significant value in its unique technology and because of the strength of the management team, clinicians, partners and investors. Having obtained regulatory approval and CE Mark in Europe, we are focused on completing our U.S. pivotal clinical study and achieving FDA Clearance."- Patrick MacCarthy, CEO

​

Learn more here

bottom of page